Company: OTSA
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061733
Chunk: 64

Company: OTSAW Ltd
Filing Date: 2025-07-07
Form: F-1/A
Chunk 64
---
 or not such publicity is related to their collaboration with us. Our ability to successfully build our brand could also be adversely affected by perceptions about the quality of our partners’ products. With our joint venture with Swisslog Healthcare, we became subject to risks associated with Swisslog Healthcare’s business, many of which are the same risks that we currently face. Other risks include: risks associated with Swisslog Healthcare’s products and technology, integration risks, such as risks associated with combining two organizations and cultures across Singapore and Europe, two different geographies, maintaining focus on business and product development objectives, maintaining customer and supplier relationships, integrating systems and maintaining cybersecurity, allocating resources appropriately across product offerings and retaining employees, and risks associated with whether we can achieve the expected benefits of the joint venture. If we are unable to effectively manage these and any other risks resulting from the Otsaw -SwisslogJV, the value of our investment in the Otsaw -SwisslogJV may be adversely affected and the expected benefits of the planned partnership may not be realized. We expect that strategic alliance and partnership will be an important factor in the growth and success of our business. However, we may not be able to identify or secure suitable business relationship opportunities in the future or our competitors may capitalize on such opportunities before we do. Moreover, identifying such opportunities could require substantial management time and resources, and negotiating and financing relationships involves significant costs and uncertainties. If we are unable to successfully source and execute on strategic relationship opportunities in the future, our overall growth could be impaired, and our business, prospects, financial condition and operating results could be materially and adversely affected. The loss of one or more of our key personnel, or our failure to attract and retain other highly qualified personnel in the future, could harm our business. Our future success depends in a large part upon the continued service of key members of our senior management team, in particular our chairman, director and chief executive officer, Mr. Ling Ting Ming. These individuals play a key role in leading our company, implementing corporate strategies, developing our technologies, maintaining key relationships with our customers, suppliers and partners, and successfully commercializing our products and services. The loss of any key personnel could seriously harm our business. The loss of any member of our senior management team might significantly delay or prevent the achievement of our business objectives and could materially harm our business and customer relationships. In addition, because of the highly technical nature of our products, any significant loss of our existing and future engineering personnel could have a material adverse effect on our business and operating